Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-20 11:56 am Sale | 13G | Biodexa Pharmaceuticals Plc BDRX | Brio Capital Master Fund Ltd. | 167,681 0.900% | -1,260,180 (-88.26%) | View |
| 2024-11-14 5:12 pm Sale | 13G | Biodexa Pharmaceuticals Plc BDRX | Iroquois Capital Management LLC | 112,077 0.670% | -1,120,663,923 (-99.99%) | View |
| 2024-11-12 4:30 pm Sale | 13G | Biodexa Pharmaceuticals Plc BDRX | Bigger Capital LLC | 69,260,800 11.000% | -172,373,600 (-71.34%) | View |
| 2024-11-07 4:51 pm Sale | 13G | Biodexa Pharmaceuticals Plc BDRX | Cavalry Fund I LP | 0 0.000% | -116,195,174 (Position Closed) | View |
| 2024-08-08 4:24 pm Unchanged | 13G | Biodexa Pharmaceuticals Plc BDRX | Iroquois Capital Management LLC | 1,120,776,000 9.990% | 0 (Unchanged) | View |
| 2024-07-23 3:09 pm Purchase | 13G | Biodexa Pharmaceuticals Plc BDRX | Brio Capital Master Fund Ltd. | 1,427,861 9.830% | 1,427,861 (New Position) | View |
| 2024-02-14 8:47 pm Purchase | 13G | Biodexa Pharmaceuticals Plc BDRX | Ionic Ventures LLC | 135,532 4.900% | 135,532 (New Position) | View |
| 2024-02-14 2:42 pm Purchase | 13G | Biodexa Pharmaceuticals Plc BDRX | ARMISTICE CAPITAL LLC | 24,951 0.940% | 24,951 (New Position) | View |
| 2024-02-14 2:14 pm Unchanged | 13G | Biodexa Pharmaceuticals Plc BDRX | CVI Investments Inc. | 0 0.000% | 0 (Unchanged) | View |
| 2024-02-13 4:33 pm Purchase | 13G | Biodexa Pharmaceuticals Plc BDRX | Cavalry Fund I LP | 116,195,174 9.900% | 5,637,174 (+5.10%) | View |
| 2024-02-12 4:30 pm Purchase | 13G | Biodexa Pharmaceuticals Plc BDRX | Bigger Capital LLC | 241,634,400 9.900% | 241,634,400 (New Position) | View |
| 2024-01-08 4:01 pm Purchase | 13G | Biodexa Pharmaceuticals Plc BDRX | Mercer Street Global Opportunity Fund LLC | 109,396,800 9.990% | 109,396,800 (New Position) | View |
| 2023-12-28 4:30 pm Purchase | 13G | Biodexa Pharmaceuticals Plc BDRX | Cavalry Fund I LP | 110,558,000 9.900% | 110,558,000 (New Position) | View |
| 2023-03-06 06:01 am Purchase | 13G | Biodexa Pharmaceuticals Plc BDRX | Ionic Ventures LLC | 18,036,925 9.990% | 18,036,925 (New Position) | View |
| 2023-02-21 11:10 am Purchase | 13G | Biodexa Pharmaceuticals Plc BDRX | CVI Investments Inc. | 10,834,000 6.200% | 10,834,000 (New Position) | View |
| 2023-02-14 1:50 pm Purchase | 13G | Biodexa Pharmaceuticals Plc BDRX | ARMISTICE CAPITAL LLC | 386,828 8.930% | 386,828 (New Position) | View |
| 2020-07-10 10:48 am Sale | 13G | Biodexa Pharmaceuticals Plc BDRX | BlackRock Inc. BLK | 916,705 1.900% | -2,974,579 (-76.44%) | View |
| 2020-06-09 4:52 pm Sale | 13G | Biodexa Pharmaceuticals Plc BDRX | BlackRock Inc. BLK | 3,891,284 9.900% | -74,851,117 (-95.06%) | View |
| 2020-03-09 4:31 pm Purchase | 13G | Biodexa Pharmaceuticals Plc BDRX | BlackRock Inc. BLK | 78,742,401 16.800% | 78,742,401 (New Position) | View |
| 2020-02-14 2:04 pm Sale | 13G | Biodexa Pharmaceuticals Plc BDRX | ARMISTICE CAPITAL LLC | 1,233,974 4.990% | -44,701,586 (-97.31%) | View |